The Use of Nasal Phenylephrine in Infants With Bronchiolitis

Akron Children's Hospital

Status and phase: Completed; Phase 2

Conditions: Bronchiolitis

Treatments: Drug: Phenylephrine

Study type: Interventional

Funder types: Other

Identifiers

NCT00373802

NASAL #9579

Details and patient eligibility

About

Drops of either saline or phenylephrine are placed in the nose of infants less than 12 months of age to determine if it helps them to breathe easier.

Sex: All

Ages: 4 weeks to 12 months old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age 4 weeks to 12 months; admitting diagnosis of bronchiolitis; admitted to hospital's bronchiolitis pathway, admitted during weekdays, need for nasal suctioning.

Exclusion criteria

• Congenital heart disease, history of hypertension, previous wheezing, prior use of inhaled corticosteroids, gestational age at birth of <34 weeks.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind